Abstract
Radiation therapy aims to deliver high radiation dose to tumor target with minimal exposure to surrounding normal tissue. However, he physics of energy decomposition and mechanical limitations restrict the achievable dose distribution, necessitating tradeoffs between target coverage and normal tissue sparing. Treatment planning is the process of obtaining control parameters to yield such a dose pattern. Dose volume histograms (DVHs) are common tools in radiation therapy treatment planning to characterize plan quality and used as objective functions. Despite their efficacy as a compact statistical summary of dose pattern, DVHs provides limited spatial information as a report quantity and insufficient control as optimization objectives. This limitation is particularly severe for treatment site with complex geometry, as in the case of head and neck, with the presence of multi-level target volumes and various adjacent organs at risk (OARs). This paper discussed a method for dose carving, by modifying the optimization objective in the treatment planning system. Motivated by the emergent compressive sensing techniques, we introduce an objective function whose minimization leads to more direct tradeoff between target coverage and OAR sparing, sharper dose dropoff and better target dose homogeneity, achieving a better “carving” in the dose distribution. This principle, though generally applicable to all sites, is particularly beneficial for cases with complex geometry, such as head and neck planning.
Keywords: Dose carving, optimization, sparsity, treatment planning.
Current Cancer Therapy Reviews
Title:Optimization Towards Dose Carving for Head and Neck Treatment Planning
Volume: 10 Issue: 4
Author(s): Dan Ruan, George Sayre and Daniel A. Low
Affiliation:
Keywords: Dose carving, optimization, sparsity, treatment planning.
Abstract: Radiation therapy aims to deliver high radiation dose to tumor target with minimal exposure to surrounding normal tissue. However, he physics of energy decomposition and mechanical limitations restrict the achievable dose distribution, necessitating tradeoffs between target coverage and normal tissue sparing. Treatment planning is the process of obtaining control parameters to yield such a dose pattern. Dose volume histograms (DVHs) are common tools in radiation therapy treatment planning to characterize plan quality and used as objective functions. Despite their efficacy as a compact statistical summary of dose pattern, DVHs provides limited spatial information as a report quantity and insufficient control as optimization objectives. This limitation is particularly severe for treatment site with complex geometry, as in the case of head and neck, with the presence of multi-level target volumes and various adjacent organs at risk (OARs). This paper discussed a method for dose carving, by modifying the optimization objective in the treatment planning system. Motivated by the emergent compressive sensing techniques, we introduce an objective function whose minimization leads to more direct tradeoff between target coverage and OAR sparing, sharper dose dropoff and better target dose homogeneity, achieving a better “carving” in the dose distribution. This principle, though generally applicable to all sites, is particularly beneficial for cases with complex geometry, such as head and neck planning.
Export Options
About this article
Cite this article as:
Ruan Dan, Sayre George and A. Low Daniel, Optimization Towards Dose Carving for Head and Neck Treatment Planning, Current Cancer Therapy Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/157339471004150407130422
DOI https://dx.doi.org/10.2174/157339471004150407130422 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue "Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics" aims to explore cutting-edge developments and innovative strategies in the field of lipid nanoparticle (LNP) technology, particularly focusing on its application in mRNA delivery. This topic has gained unprecedented attention and urgency in the wake of the COVID-19 ...read more
Current Progress in Protein Degradation and Cancer Therapy
Targeted Protein Degradation is gaining momentum in cancer therapy; it facilitates targeting undruggable proteins, overcomes cancer resistance, and avoids undesirable side effects. Thus small molecule degraders have emerged as novel therapeutic strategies. Targeted protein degradation (TPD), the process of eliminating a protein of interest holds a great promise for the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design
Current Topics in Medicinal Chemistry Phytochemicals as Potential Curative Agents against Viral Infection: A Review
Current Organic Chemistry Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer
Current Medicinal Chemistry MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
Current Medicinal Chemistry From the Sea to Anticancer Therapy
Current Medicinal Chemistry HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews Targeting Angiogenesis in Thyroid Cancer
Current Angiogenesis (Discontinued) HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis
Current Topics in Medicinal Chemistry The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer
Current Pharmaceutical Design Mitosis-Targeting Natural Products for Cancer Prevention and Therapy
Current Drug Targets Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Bowman-Birk Inhibitors from Legumes and Human Gastrointestinal Health: Current Status and Perspectives
Current Protein & Peptide Science Cetuximab and the Head and Neck Squamous Cell Cancer
Current Topics in Medicinal Chemistry Cytotoxic and Radio-sensitizing Effects of Polyphenolic Acetates in a Human Glioma Cell Line (BMG-1)
Current Pharmaceutical Design